CARDINAL HEALTH INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net earnings $1.4b
$1.3b -9.57%
$259.0m -79.98%
$1.4b +427.03%
($3.7b) -370.55%
$612.0m +116.57%
($932.0m) -252.29%
$262.0m +128.11%
$853.0m +225.57%
$1.6b +83.94%
Net Income (Loss) Attributable to Parent $1.4b $256.0m
$1.4b +432.42%
($3.7b) -371.17%
$611.0m +116.53%
($933.0m) -252.70%
$261.0m +127.97%
$852.0m +226.44%
$1.6b +83.22%
Net Income (Loss) Attributable to Noncontrolling Interest $4.0m $6.0m $3.0m $2.0m $3.0m $1.0m $1.0m $1.0m $1.0m $8.0m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $1.4b $1.3b $259.0m $1.4b ($3.7b) $612.0m ($932.0m) $262.0m $853.0m $1.6b
Amortization of Intangible Assets $355.0m $395.0m $574.0m $531.0m $512.0m $428.0m $311.0m $281.0m $264.0m $303.0m
Depreciation $277.0m $314.0m $446.0m $455.0m $405.0m $377.0m $412.0m $441.0m $470.0m $488.0m $924.0m
Depreciation, Depletion and Amortization $641.0m $717.0m $1.0b $1.0b $913.0m $783.0m $692.0m $692.0m $710.0m $790.0m $924.0m
Deferred Income Tax Expense (Benefit) $87.0m $291.0m ($1.0b) ($83.0m) ($961.0m) $496.0m $7.0m ($31.0m) ($104.0m) $243.0m $243.0m
Net tax proceeds/(withholding) from share-based compensation $6.0m $26.0m ($3.0m) ($14.0m) $8.0m $8.0m ($19.0m) $56.0m $46.0m ($13.0m)
Share-based Payment Arrangement, Expense $111.0m $96.0m $85.0m $82.0m $90.0m $89.0m $81.0m $96.0m $121.0m $121.0m $462.0m
Share-based Payment Arrangement, Noncash Expense $111.0m $96.0m $85.0m $82.0m $90.0m $89.0m $81.0m $96.0m $121.0m $244.0m $462.0m
Share-based compensation $111.0m $96.0m $85.0m $82.0m $90.0m $89.0m $81.0m $96.0m $121.0m $244.0m $462.0m
Gain (Loss) on Sale of Assets and Asset Impairment Charges ($21.0m) ($18.0m) ($1.4b) $488.0m ($7.0m) ($79.0m) ($2.0b) ($1.2b) ($634.0m) ($18.0m)
Goodwill, Impairment Loss $1.4b $0 $2.1b $1.2b $675.0m $227.0m
Impairments and (gain)/loss on disposal of assets, net $21.0m $18.0m $1.4b ($488.0m) $7.0m $79.0m $2.0b $1.2b $634.0m $18.0m
Impairments and loss on sale of other investments $3.0m $0 $0 $24.0m $7.0m $2.0m $3.0m
Income (Loss) from Equity Method Investments $2.0m
Other Nonoperating Income (Expense) ($5.0m) $5.0m ($23.0m) ($15.0m) $1.0m $47.0m ($16.0m) $4.0m $9.0m $41.0m
Changes in operating assets and liabilities:
Increase in trade receivables ($866.0m) ($665.0m) ($871.0m) ($751.0m) $82.0m ($904.0m) ($1.5b) ($947.0m) ($996.0m) ($833.0m)
Increase (Decrease) in Inventories $1.2b $673.0m $1.2b $551.0m $409.0m $1.6b $1.1b $340.0m ($1.1b) $1.8b ($1.8b)
Inventory Write-down $197.0m
Increase (Decrease) in Accounts Payable $2.8b $564.0m $2.6b $1.9b ($162.0m) $2.3b $3.4b $2.7b $1.8b $2.7b $4.8b
Increase in accounts payable $2.8b $564.0m $2.6b $1.9b ($162.0m) $2.3b $3.4b $2.7b $1.8b $2.7b
Other accrued liabilities and operating items, net ($147.0m) ($520.0m) $378.0m $193.0m $6.5b $452.0m $293.0m ($967.0m) ($433.0m) ($606.0m)
Net Cash Provided by (Used in) Operating Activities $3.0b
$1.2b -60.15%
$2.8b +133.78%
$2.7b -1.66%
$2.0b -27.99%
$2.4b +23.93%
$3.1b +28.53%
$2.8b -9.06%
$3.8b +32.51%
$2.4b -36.28%
$5.0b +108.68%
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $465.0m $387.0m $384.0m $328.0m $375.0m $400.0m $387.0m $481.0m $511.0m $547.0m ($617.0m)
Gain (Loss) on Sale of Investments $3.0m $0 ($2.0m) $2.0m $0 $0 $3.0m
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale $50.0m $77.0m $0 $0
Payments to Acquire Businesses, Net of Cash Acquired $3.6b $132.0m $6.1b $82.0m $0 $3.0m $22.0m $10.0m $1.2b $5.2b ($3.4b)
Increase (decrease) in other investing items, net $8.0m $18.0m $2.0m
Net Cash Provided by (Used in) Investing Activities ($4.1b) ($405.0m) ($5.6b) $338.0m $493.0m ($378.0m) $567.0m ($454.0m) ($1.8b) ($5.6b) ($3.9b)
Cash flows from financing activities:
Gain (Loss) on Extinguishment of Debt $0 $0 ($2.0m) $0 ($16.0m) ($14.0m) ($10.0m) $0 $0
Proceeds from Issuance of Long-term Debt $0 $5.2b $3.0m $0 $0 $0 $0 $1.1b $2.9b $1.8b
Provision for bad debts $73.0m $63.0m $111.0m $88.0m $106.0m $65.0m $68.0m $99.0m $36.0m $53.0m
Repayments of Long-term Debt $6.0m $310.0m $954.0m $1.1b $1.4b $570.0m $885.0m $579.0m $783.0m $445.0m ($648.0m)
Payments for Repurchase of Common Stock $651.0m $600.0m $550.0m $600.0m $350.0m $200.0m $1.0b $2.0b $750.0m $765.0m
Payments of Ordinary Dividends, Common Stock $512.0m $577.0m $581.0m $577.0m $569.0m $573.0m $559.0m $525.0m $499.0m $494.0m ($491.0m)
Dividends on common shares ($512) ($577) ($581) ($577) ($569) ($573) ($559) ($525) ($499) ($494)
Net Cash Provided by (Used in) Financing Activities ($1.1b)
$3.7b +428.88%
($2.3b) -160.76%
($2.3b) -0.75%
($2.2b) +4.06%
($1.3b) +40.14%
($2.5b) -87.02%
($3.1b) -23.87%
($847.0m) +72.24%
$1.9b +329.04%
($449.0m) -123.14%
Net increase/(decrease) in cash and equivalents ($2.3b) $4.5b ($5.1b) $768.0m $240.0m $636.0m $1.3b ($674.0m) $1.1b ($1.3b)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($12.0m) ($2.0m) $4.0m $1.0m $240.0m $636.0m $1.3b ($674.0m) $1.1b ($1.3b) $3.9b
Cash and equivalents at beginning of period $4.6b $2.4b $6.9b $1.8b $2.5b $2.8b $4.7b $4.0b $5.1b $3.9b
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.7b $4.0b $5.1b $3.9b $3.9b
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($12.0m) ($2.0m) $4.0m $1.0m ($13.0m) $11.0m ($25.0m) ($8.0m) ($9.0m) ($3.0m) ($8.0m)
Effect of exchange rates changes on cash and equivalents ($12.0m) ($2.0m) $4.0m $1.0m ($13.0m) $11.0m ($25.0m) ($8.0m) ($9.0m) ($3.0m)
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Acquisition of subsidiaries, net of cash acquired ($3.6b) ($132.0m) ($6.1b) ($82.0m) $0 ($3.0m) ($22.0m) ($10.0m) ($1.2b) ($5.2b)
Additional Financial Items
Cash payments for interest $174.0m $200.0m $320.0m $285.0m $226.0m $182.0m $153.0m $203.0m $214.0m $315.0m
Gain (Loss) Related to Litigation Settlement $69.0m ($48.0m) ($159.0m) ($36.0m) ($5.7b) ($1.1b) ($109.0m) $302.0m ($78.0m) $185.0m
Goodwill $7.2b $7.2b $8.3b $8.4b $8.4b $8.0b $5.9b $4.6b $4.7b $9.7b $227.0m
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $1.4b $1.3b
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $1.4b $1.3b
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $0 $0
Income Tax Expense (Benefit) $845.0m $630.0m ($487.0m) $386.0m ($79.0m) ($289.0m) $163.0m $376.0m $348.0m $532.0m
Income Taxes Paid, Net $635.0m $686.0m $425.0m $311.0m $368.0m $273.0m ($766.0m) $156.0m $191.0m $444.0m
Interest Paid, Excluding Capitalized Interest, Operating Activities $174.0m $200.0m $320.0m $285.0m $226.0m $182.0m $153.0m $203.0m $214.0m $315.0m
Proceeds from long-term obligations, net of issuance costs $0 $5.2b $3.0m $0 $0 $0 $0 $1.1b $3.7b
Proceeds from net investment hedge terminations $0 $0 $71.0m $29.0m $34.0m $2.0m
Proceeds from short-term investment in time deposit $0 $0 $350.0m $200.0m
Purchase of noncontrolling interests ($10.0m) ($12.0m) ($106.0m) $0 $0 $0 $3.0m $0 $12.0m
Purchase of short-term time deposits $0 $0 ($550.0m) $0
Purchase of treasury shares ($651.0m) ($600.0m) ($550.0m) ($600.0m) ($350.0m) ($200.0m) ($1.0b) ($2.0b) ($750.0m) ($765.0m)
Reduction of long-term obligations ($6.0m) ($310.0m) ($954.0m) ($1.1b) ($1.4b) ($570.0m) ($885.0m) ($579.0m) ($783.0m) ($445.0m)
Restructuring Costs $19.0m $44.0m $150.0m $92.0m $109.0m $75.0m $59.0m $43.0m $87.0m $40.0m
Supplemental disclosure of cash flow information:

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.